INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP)

CUSIP: 46137V662

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / PHARMACEUTICALS
Total 13F shares
968,120
Share change
+193,191
Total reported value
$69,031,328
Price per share
$71.30
Number of holders
79
Value change
+$13,740,443
Number of buys
29
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 46137V662?
CUSIP 46137V662 identifies PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2022

As of 30 Sep 2022, INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 968,120 shares. The largest 10 holders included MORGAN STANLEY, Peak Asset Management, LLC, Mirae Asset Global Investments Co., Ltd., GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, UBS Group AG, LPL Financial LLC, WELLS FARGO & COMPANY/MN, Federation des caisses Desjardins du Quebec, and COMMONWEALTH EQUITY SERVICES, LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.